Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Flat Medical develops and commercializes EpiFaith, a visualized loss-of-resistance syringe to improve safety and accuracy of epidural procedures, with CE mark and FDA clearance obtained in 2019 and early clinical use in leading hospitals across the US and Europe; it is expanding into central line access (EpiFaith CV) and bioimpedance-based smart needle applications (IQ-Tip) following acquisition of InjeQ assets.[1][2][3]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Flat Medical.